The company and two of its subsidiaries allegedly “flouted their legal obligations and prioritized profits” over people, the Justice Department said. The lawsuit seeks unspecified damages.
“The United States brings this suit to hold defendants accountable for their egregious failure to report suspicious orders and their role in contributing to the opioid epidemic,” the Justice Department said in the news release.
AmerisourceBergen and two other major U.S. drug distributors reached a multibillion-dollar settlement with a group of state attorneys general to resolve most of the opioid lawsuits filed against them.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
